Iridex (IRIX) Divestments (2012 - 2013)
Iridex's quarterly Divestments came in at $510000.0 in Q2 2013, down 88.99% quarter-over-quarter from $4.6 million in Q1 2012.
Iridex has reported Divestments for 2 years, with the latest figure at $510000.0 in Q2 2013.
- For the quarter ending Q2 2013, Divestments changed N/A year-over-year to $510000.0; the trailing twelve-month figure through Dec 2013 stood at $510000.0 (down 88.99% YoY), and the FY2013 full-year result was $510000.0, down 88.99% from the prior year.
- Divestments for Q2 2013 stood at $510000.0, down from $4.6 million in the prior quarter.
- The five-year high for Divestments was $4.6 million in Q1 2012, with the low at $510000.0 in Q2 2013.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Iridex | 18.87 Mn | 14.27 Mn | 4.74 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 29, 2013 | 510,000.00 |
| Mar 31, 2012 | 4.63 Mn |